A
Amarna Therapeutics
Uses a viral platform to deliver transgenes into humans
About Amarna Therapeutics
Amarna Therapeutics, founded in 2008, is a privately held biotech company specializing in the development of the SVac viral gene delivery vector platform. This platform is designed to transform the treatment landscape across various disease areas, including autoimmune disorders and other significant health conditions. The SVac platform is known for its safety, high efficiency, and non-immunogenic properties, making it a groundbreaking tool in the field of gene and immune therapies. The company operates in the biotech sector, primarily serving pharmaceutical companies, research institutions, and healthcare providers looking for advanced gene therapy solutions. Amarna's business model revolves around the development and licensing of its SVac platform, generating revenue through partnerships, collaborations, and licensing agreements. The SVac platform's cost-effective production in the SuperVero packaging cell line further enhances its commercial viability.
Source: Dealroom company dataNews
Open roles
Amarna Therapeutics in the Leiden ecosystem
The Amarna Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Eureka
Series A1 investor entered at this stage
Flerie Invest
Series B and later2 investors entered at this stage
- FAFlerie Make investments AB
- CBC4 holding BV
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Amarna Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Amarna Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


